Frustrating stock, but looks to have a future, patients are required.
Past few months there has been some heavy selling with a top 20 holder selling out, doesnt help the small cap company at all.
Through PBI they have started to get a good revenue stream, that now are trying to expand on that.
The way i see it, if they were to get a favourable decision from either Merial or the FDA, then the stock would have some blue sky about it, until then its probably worth somewhere between 5-10c on speculation.
Hope this helps
Cheers :-)
STI Price at posting:
0.0¢ Sentiment: None Disclosure: Held
